• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A randomized trial of human chorionic gonadotropin support following in vitro fertilization and embryo transfer.

作者信息

Buvat J, Marcolin G, Herbaut J C, Dehaene J L, Verbecq P, Fourlinnie J C

机构信息

Association EPARP, Lille, France.

出版信息

Fertil Steril. 1988 Mar;49(3):458-61. doi: 10.1016/s0015-0282(16)59773-8.

DOI:10.1016/s0015-0282(16)59773-8
PMID:3277865
Abstract

This article reports on the effects of human chorionic gonadotropin (hCG) on progesterone (P) and estradiol (E2), luteal phase length, and conception in 116 cycles treated by in vitro fertilization and embryo transfer (IVF-ET). In 60 cycles, the luteal phase was supported by hCG, 1500 IU three times at 2-day intervals from the day of ET. The remaining 56 cycles served as controls. hCG significantly increased the P level (93 +/- 53 versus 62 +/- 46 ng/ml), the P/E2 ratio, and the luteal phase length (17.4 +/- 1.3 versus 12.2 +/- 1.7 days). However, the total pregnancy rate did not significantly differ between the two groups, though the pregnancy rate after transfer of two or three embryos was slightly higher in the hCG group (26.9 versus 22% in the control group), as was the rate of implanted embryo per transferred embryo after transfer of two or three embryos (25 versus 15.3%). It was concluded that, while hCG increased the magnitude and duration of the luteal P secretion, it did not clearly improve the pregnancy rate.

摘要

相似文献

1
A randomized trial of human chorionic gonadotropin support following in vitro fertilization and embryo transfer.
Fertil Steril. 1988 Mar;49(3):458-61. doi: 10.1016/s0015-0282(16)59773-8.
2
Luteal-phase support in stimulated cycles in an in vitro fertilization/embryo transfer program: progesterone versus human chorionic gonadotropin.
J In Vitro Fert Embryo Transf. 1988 Apr;5(2):81-4. doi: 10.1007/BF01130663.
3
Luteal support after luteinizing hormone-releasing hormone agonist for in vitro fertilization: superiority of human chorionic gonadotropin over oral progesterone.用于体外受精的促黄体生成素释放激素激动剂后的黄体支持:人绒毛膜促性腺激素优于口服孕酮。
Fertil Steril. 1990 Mar;53(3):490-4. doi: 10.1016/s0015-0282(16)53346-9.
4
Luteal rescue in in vitro fertilization-embryo transfer.体外受精-胚胎移植中的黄体挽救
Fertil Steril. 1990 Mar;53(3):495-501.
5
A prospective randomized trial of human chorionic gonadotrophin or dydrogesterone support following in-vitro fertilization and embryo transfer.体外受精与胚胎移植后使用人绒毛膜促性腺激素或炔羟孕酮支持的前瞻性随机试验。
Hum Reprod. 1990 Apr;5(3):271-3. doi: 10.1093/oxfordjournals.humrep.a137087.
6
Effects of low-dose human chorionic gonadotropin on corpus luteum function after embryo transfer.低剂量人绒毛膜促性腺激素对胚胎移植后黄体功能的影响。
J In Vitro Fert Embryo Transf. 1985 Dec;2(4):190-4. doi: 10.1007/BF01201796.
7
Luteal phase support in in-vitro fertilization using gonadotrophin releasing hormone analogue before ovarian stimulation: a prospective randomized study of human chorionic gonadotrophin versus intramuscular progesterone.在卵巢刺激前使用促性腺激素释放激素类似物的体外受精中黄体期支持:人绒毛膜促性腺激素与肌肉注射黄体酮的前瞻性随机研究
Hum Reprod. 1992 Apr;7(4):487-9. doi: 10.1093/oxfordjournals.humrep.a137676.
8
Pregnancy rate and ovarian hyperstimulation after luteal human chorionic gonadotropin in in vitro fertilization stimulated with gonadotropin-releasing hormone analog and menotropins.在使用促性腺激素释放激素类似物和尿促性素刺激的体外受精中,黄体期注射人绒毛膜促性腺激素后的妊娠率及卵巢过度刺激情况
Fertil Steril. 1990 Jan;53(1):92-6. doi: 10.1016/s0015-0282(16)53222-1.
9
Salivary oestradiol and progesterone after in vitro fertilization and embryo transfer using different luteal support regimens.使用不同黄体支持方案进行体外受精和胚胎移植后的唾液雌二醇和孕酮
Reprod Fertil Dev. 1990;2(4):351-8. doi: 10.1071/rd9900351.
10
Serum progesterone levels in women treated with human menopausal gonadotropin and human chorionic gonadotropin for in vitro fertilization.
Fertil Steril. 1986 Nov;46(5):903-6. doi: 10.1016/s0015-0282(16)49832-8.

引用本文的文献

1
Luteal phase support for assisted reproduction cycles.辅助生殖周期的黄体期支持。
Cochrane Database Syst Rev. 2015 Jul 7;2015(7):CD009154. doi: 10.1002/14651858.CD009154.pub3.
2
The optimum time for exogenous human chorionic gonadotropin to rescue the corpus luteum.外源性人绒毛膜促性腺激素挽救黄体的最佳时间。
J Assist Reprod Genet. 1999 Oct;16(9):495-9. doi: 10.1023/a:1020507217897.
3
A comparative, randomized study of three different progesterone support of the luteal phase following IVF/ET program.
J Endocrinol Invest. 1995 Jan;18(1):51-6. doi: 10.1007/BF03349699.
4
Drugs used in in vitro fertilisation procedures.体外受精程序中使用的药物。
Drugs. 1989 Jul;38(1):148-59. doi: 10.2165/00003495-198938010-00006.
5
Trial of support treatment with human chorionic gonadotrophin in the luteal phase after treatment with buserelin and human menopausal gonadotrophin in women taking part in an in vitro fertilisation programme.参与体外受精项目的女性在使用布舍瑞林和人绝经期促性腺激素治疗后,于黄体期用人绒毛膜促性腺激素进行支持治疗的试验。
BMJ. 1989 Jun 3;298(6686):1483-6. doi: 10.1136/bmj.298.6686.1483.